SH2B3 and ovarian cancer: These results confirmed that LNK mainly activates the p-ERK1/2 pathway, and in addition, have a certain degree of activation with the p-STAT5, p-AKT and p-STAT3 pathways, thereby promoting breast cancer cell proliferation and migration ability, which is similar to the studies in Ovarian cancer [14].